Articles with "telbivudine" as a keyword



Photo by niaid from unsplash

Telbivudine attenuates UUO‐induced renal fibrosis via TGF‐&bgr;/Smad and NF‐&kgr;B signaling

Sign Up to like & get
recommendations!
Published in 2018 at "International Immunopharmacology"

DOI: 10.1016/j.intimp.2017.11.043

Abstract: ABSTRACT Renal fibrosis yields decreased renal function and is a potent contributor to chronic kidney disease (CKD). Telbivudine (LdT) is an anti–hepatitis B virus (HBV) drug that has been found to steadily improve renal function,… read more here.

Keywords: bgr smad; fibrosis; kgr; renal fibrosis ... See more keywords

Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus

Sign Up to like & get
recommendations!
Published in 2017 at "Journal of Gastroenterology and Hepatology"

DOI: 10.1111/jgh.13436

Abstract: The efficacy of telbivudine for breaking vertical transmission of hepatitis B virus has been well established. Data on the risk of postpartum flare after telbivudine withdrawal and efficacy of extended antiviral therapy after delivery are… read more here.

Keywords: flare telbivudine; efficacy; telbivudine withdrawal; withdrawal efficacy ... See more keywords
Photo from wikipedia

Safety and efficacy of telbivudine in late pregnancy to prevent mother‐to‐child transmission of hepatitis B virus: A multicenter prospective cohort study

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Viral Hepatitis"

DOI: 10.1111/jvh.12834

Abstract: Infection of hepatitis B virus (HBV) occurs in ~10% of infants of HBV‐infected mothers with positive hepatitis B e antigen (HBeAg) after immunoprophylaxis. We aimed to evaluate the safety and efficacy of telbivudine used during… read more here.

Keywords: pregnancy; hepatitis; transmission; hbv ... See more keywords
Photo from wikipedia

Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial

Sign Up to like & get
recommendations!
Published in 2017 at "BMC Gastroenterology"

DOI: 10.1186/s12876-017-0572-2

Abstract: BackgroundTelbivudine has been suggested to induce hepatitis B surface antigen (HBsAg) decline to the similar degree as pegylated interferon. We aimed to investigate whether telbivudine could further decrease HBsAg titer in patients who maintain undetectable… read more here.

Keywords: entecavir; trial; dna; hepatitis ... See more keywords